Hepatitis B Reactivation
What is Hepatitis B Reactivation?
Hepatitis B reactivation happens when a hepatitis B virus infection that was dormant or controlled becomes active again. The virus can hide in your liver cells for years without causing symptoms. When your immune system becomes weakened, the virus can wake up and start multiplying again.
This condition is different from a new hepatitis B infection. People who had hepatitis B in the past or were exposed to the virus can experience reactivation even if they thought they had recovered. The reactivated virus can damage your liver and cause serious health problems if not detected early.
Hepatitis B reactivation is most common in people taking medications that suppress the immune system. This includes chemotherapy, drugs for autoimmune diseases, and medications given after organ transplants. Without proper monitoring and treatment, reactivation can lead to liver inflammation, liver failure, or even death.
Symptoms
- Fatigue and weakness that interferes with daily activities
- Loss of appetite and unintended weight loss
- Nausea and vomiting
- Abdominal pain, especially in the upper right side
- Dark urine that looks brown or tea-colored
- Pale or clay-colored stools
- Yellowing of the skin and eyes, called jaundice
- Fever and chills
- Joint pain and muscle aches
Many people with hepatitis B reactivation have no symptoms in the early stages. The virus can be actively multiplying and damaging your liver before you feel sick. This is why blood testing is essential for people at risk, especially those starting immunosuppressive therapy.
Concerned about Hepatitis B Reactivation? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Hepatitis B reactivation occurs when your immune system can no longer keep the virus suppressed. The most common trigger is immunosuppressive therapy, which includes chemotherapy for cancer, medications for rheumatoid arthritis or inflammatory bowel disease, and drugs given to prevent organ rejection after transplants. Steroids used long-term can also weaken immune defenses enough to allow the virus to reactivate.
Other risk factors include having HIV or AIDS, undergoing dialysis for kidney disease, and having a history of hepatitis B infection even if it seemed resolved. People born in regions where hepatitis B is common, such as parts of Asia and Africa, have higher rates of past infection. Even people who were infected as children and appeared to clear the virus can harbor dormant viral DNA in their liver cells for life.
How it's diagnosed
Hepatitis B reactivation is diagnosed through blood tests that detect viral markers and measure liver function. The Hepatitis B Surface Antigen test, or HBsAg, shows if active virus is present in your blood. During reactivation, this marker can reappear or increase even if it was previously undetectable. The Hepatitis Be Antibody test helps identify changes in viral activity, as its reappearance may signal that dormant infection is becoming active again.
Rite Aid offers hepatitis B testing as an add-on to our blood panel at Quest Diagnostics locations nationwide. If you are starting immunosuppressive therapy or have risk factors for reactivation, regular monitoring can catch the virus before it causes serious liver damage. Your doctor may also order liver enzyme tests to check for signs of inflammation and viral load tests to measure how much virus is in your blood.
Treatment options
- Antiviral medications such as entecavir, tenofovir, or lamivudine to suppress viral replication
- Starting antiviral therapy before beginning immunosuppressive treatment if you have a history of hepatitis B
- Regular blood tests every few months to monitor viral levels and liver function
- Adjusting immunosuppressive medications when possible to reduce reactivation risk
- Avoiding alcohol completely, as it adds stress to your liver
- Eating a balanced diet rich in fruits, vegetables, and lean proteins to support liver health
- Getting adequate rest and managing stress to support immune function
- Vaccination for hepatitis A if not already immune, to prevent additional liver strain
Need testing for Hepatitis B Reactivation? Add it to your panel.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
A new hepatitis B infection means you are being exposed to the virus for the first time. Hepatitis B reactivation happens when a past infection that was dormant becomes active again. People with reactivation already have the virus hiding in their liver cells, and it wakes up when the immune system becomes weak.
People taking immunosuppressive medications face the highest risk, especially those receiving chemotherapy or biologic drugs for autoimmune diseases. Anyone with a history of hepatitis B infection, even if it seemed resolved years ago, can experience reactivation. Cancer patients, organ transplant recipients, and people with HIV are particularly vulnerable.
Yes, screening before starting immunosuppressive therapy allows doctors to identify people at risk. If you have markers of past hepatitis B infection, your doctor can start antiviral medication before beginning treatments like chemotherapy. This preventive approach reduces reactivation risk by up to 90 percent in most studies.
If you are taking immunosuppressive medications, your doctor will typically order blood tests every 1 to 3 months. Testing frequency depends on your specific medications and viral markers. People with high viral loads or liver enzyme changes may need more frequent monitoring to catch reactivation early.
The Hepatitis B Surface Antigen test shows if active virus is present and can detect reactivation when levels rise or reappear. Hepatitis Be Antibody testing helps track changes in viral activity. Your doctor may also order viral load tests and liver enzyme tests to assess how much virus is present and whether your liver is being damaged.
Yes, when the virus reactivates, you can spread it to others through blood and body fluids. This includes sexual contact, sharing needles, and from mother to baby during childbirth. People with reactivation should take precautions to protect household members and sexual partners until the virus is suppressed with treatment.
Untreated reactivation can cause severe liver inflammation, called hepatitis flare, which may progress to acute liver failure. Some people develop cirrhosis, which is permanent scarring of the liver. In the most severe cases, liver failure can be fatal, especially in people already weakened by cancer treatment or other serious illnesses.
Yes, but you will need antiviral medication to prevent reactivation. Your oncologist or specialist will work with a liver doctor to monitor your viral levels closely. With proper prophylaxis and monitoring, most people can safely receive necessary treatments for cancer or autoimmune diseases without experiencing dangerous reactivation.
No, the hepatitis B vaccine only prevents new infections in people who have never been exposed to the virus. It cannot prevent reactivation in people who already have the virus in their liver cells. However, vaccination is important for family members and close contacts of people with hepatitis B to protect them from infection.